Like Geospiza

closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/23/2021 via PR Newswire

InsightfulScience, will acquire Dotmatics

synopsis: Insightful Science, a leading software provider, will acquire UK-based Dotmatics, an industry leading cloud-based scientific R&D data management platform. By integrating Insightful Science's software applications into Dotmatics cloud-first enterprise data management solution, the company will provide an end-to-end scientific research platform.
buyer parent: Insight Venture Partners
buyer: InsightfulScience
Insightful Science is a life sciences software company that digitally connects researchers to their ideas and data. The company empowers life sciences researchers to plan effective experiments, connect with data, and extract insights so they can produce life-changing outcomes. "
target parent: Scottish Equity Partners
target: Dotmatics
UK-based Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research—accelerating the journey towards full digitalization and the Lab of the Future.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2019 via PR Newswire

InVitae, will acquire Jungla Inc.

synopsis: Invitae, a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare, will acquire Jungla, an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests.
buyer: InVitae (NVTA:$216.82)
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare. They aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Jungla Inc.
Jungla Inc. is an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests. Jungla's technologies combine advances in functional genomics, computational biophysics, cellular engineering, and computer science.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2013 via Company Press Release

Illumina, Inc., acquired NextBio, Inc.

synopsis: Illumina, Inc. has acquired Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. They provide innovative sequencing and array-based solutions. "
target: NextBio, Inc.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/26/2005 via PR Newswire

Entelos Inc., acquired Discovery Innovations, Inc.

synopsis: Entelos, Inc., the leader in biosimulation technologies for pharmaceutical research and development, announced today the acquisition of Discovery Innovations, a specialized provider of data integration products and services to the life sciences.
buyer: Entelos Inc.
Entelos partners with pharmaceutical and biotech organizations worldwide to develop effective new treatments for disease and dramatically reduce the time and cost needed to develop them. Using our patented PhysioLab technology, Entelos develops dynamic large-scale computer models of human disease. "
target: Discovery Innovations, Inc.
Discovery Innovations is a specialized provider of web-based products and information services to the life sciences. Recognizing the tidal wave of information being generated in the life sciences, Discovery Innovations has developed products and services that more efficiently access, deliver and sha
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/11/2021 via BusinessWire

Komodo Health Inc., acquired Mavens

synopsis: Komodo Health has announced its acquisition of Mavens, the pioneer in building trusted software products and implementing cloud-based technology to help biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization.
buyer: Komodo Health Inc.
At Komodo Health, they partner with their customers to improve patient care and reduce disease burden through data-driven insights. The Komodo Health Platform delivers patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems. "
target: Mavens
Mavens is the pioneer in building trusted software products and implementing cloud-based technology to help biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2019 via PR Newswire

GraphPad Software, Inc., acquired SnapGene

synopsis: GraphPad Software, the leading provider of software developed exclusively for the scientific community, announced it has acquired SnapGene, a leading bioinformatics software solution that provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
buyer: GraphPad Software, Inc.
GraphPad is the leading provider of software developed exclusively for the scientific community. GraphPad Prism, their flagship product, is the preferred analysis and graphing solution for scientific research. Prism helps scientists discover and share the story in their data. "
target: SnapGene
SnapGene was founded by scientists and software designers to meet the everyday needs of molecular biologists. Their software provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2018 via BusinessWire

Medidata Solutions Worldwide, will acquire SHYFT Analytics

synopsis: Medidata announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. "
target: SHYFT Analytics
SHYFT Analytics is the leading cloud data analytics platform for life sciences with solutions designed exclusively for the pharmaceutical and biotech industry.
price ($mm)
$195
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2016 via PR Newswire

Sunquest Information Systems, acquired UNIConnect LC

synopsis: Provider of diagnostics informatics solutions to more than 1,700 laboratories, Sunquest Information Systems, Inc. announced the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: UNIConnect LC
Based in Salt Lake City, UT, UNIConnect® L.C. has created a Laboratory Information Management System (LIMS) platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/16/2012 via BusinessWire

Tegal Corporation, acquired CollabRX, Inc

synopsis: Tegal Corporation announced the closing of a transaction to acquire CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine.
buyer: Tegal Corporation (TGAL:$0.02)
Tegal Corporation's legacy is evident in the most advanced consumer and industrial products that incorporate microprocessors, magnetic memories, radio frequency ID chips, acoustic wave devices, sensors, LEDs, and an array of other semiconductor and MEMS devices. "
target: CollabRX, Inc (CM:CLRX:$0.38)
CollabRx offers cloud-based expert systems that provide clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision making.
price ($mm)
$1.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2020 via BusinessWire

Illumina, Inc., acquired BlueBee

synopsis: Illumina, Inc. is acquiring BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina, Inc. is a biotechnology company. They provide sequencing and array-based solutions for genetic analysis. Their studies help accelerate the studies of personalized medicine and their products are used for applications in life sciences and other emerging health segments. "
target: BlueBee
BlueBee is a cloud-based software company that provides genomics analysis solutions for research and clinical customers. BlueBee has developed a regulatory compliant, secure cloud platform that simplifies access to data and tools, enabling users to easily extract insights from genomic data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/10/2020 via PR Web

HealthLytix merged with Cortechs Labs Inc,

synopsis: CorTechs Labs Inc., the leading quantitative neuroimaging software company, announced that it has merged with sister company HealthLytix, a healthcare technology company developing new applications in genetics and medical imaging to improve the screening and early detection of cancer and neurodegenerative diseases.
buyer: Cortechs Labs Inc
CorTechs Labs is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so people can enjoy longer, better lives. "
target: HealthLytix
HealthLytix is a precision health company and developer of quantitative medical imaging solutions that leverage machine learning. HealthLytix creates data analytics solutions to provide comprehensive insights into health status based on genetics, quantitative imaging, and other medical information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2019 via PR Newswire

Beckman Coulter, Inc, acquired Cytobank

synopsis: Beckman Coulter, a company that is advancing healthcare to enhance the diagnostic laboratory’s role in improving healthcare outcomes, announced its acquisition of Cytobank, a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research.
buyer parent: Danaher Corporation
buyer: Beckman Coulter, Inc (BEC:$3,260.60)
Beckman Coulter is committed to advancing healthcare by applying science, technology and the creativity of their teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Their diagnostic systems are used in complex biomedical testing and are found around the globe. "
target: Cytobank
Cytobank Inc. is a cloud-based analysis platform utilizing machine learning algorithms for collaborative biomedical research. Pharmaceutical, biotechnology, and academic researchers around the world use their SaaS solution to develop deep understandings of complex biology at the single cell level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PR Newswire

InVitae, acquired CancerGene Connect

synopsis: Invitae Corporation, one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare software, including CancerGene Connect, one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories.
buyer: InVitae (NVTA:$216.82)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: CancerGene Connect
CancerGene Connect is one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories. CancerGene Connect was developed by clinicians for clinicians to streamline the collection, analysis, and management of patient family history information.
price ($mm)
$6.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/18/2019 via BNC Analysis

NVIDIA Corporation, acquired Parabricks

synopsis: Computational technology company Nvidia has acquired sequencing analysis software developer Parabricks. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
buyer: NVIDIA Corporation (NVDA:$19,256.00)
NVIDIA Corporation is the worldwide leader in programmable graphics processor technologies. The Company creates innovative, industry-changing products for computing, consumer electronics, and mobile devices. "
target: Parabricks
Parabricks is a sequencing analysis software developer. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/11/2016 via BusinessWire

Labworks, acquired Labworks LIMS

synopsis: Labworks, LLC, the industry’s choice for robust yet simple solutions for Laboratory Information Management Systems (LIMS), announced that it has acquired the LABWORKS LIMS product line from PerkinElmer Health Sciences. The LABWORKS LIMS product line is comprised of seasoned software executives and many previous PerkinElmer/LABWORKS employees.
buyer: Labworks
Labworks’ industry-leading software features adaptive workflow, automated information transfers and tracking reports accessible via the web or e-mail, flexible enterprise system integration, and comprehensive solutions for regulatory compliance. "
target parent: PerkinElmer, Inc.
target: Labworks LIMS
The LABWORKS LIMS product family is designed for ultra-configurable deployment that can be tailored to a wide variety of laboratory needs and workflows. A flexible design helps laboratories obtain benefits faster by avoiding lengthy customization and implementation projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/29/2014 via BusinessWire

PerkinElmer, Inc., acquired Ceiba Solutions

synopsis: PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced the acquisition of Ceiba Solutions, Inc., a sciences and laboratory IT software and services company offering managed IT services and emerging software platforms.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Ceiba Solutions
Ceiba is a global products and service company dedicated to unleashing the value of Life Science and Healthcare data while reducing the cost to manage it.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/16/2011 via BusinessWire

PerkinElmer, Inc., acquired Labtronics Inc.

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook (ELN) solutions for laboratories performing routine analysis in multiple industries.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Labtronics Inc.
Labtronics Inc. is an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook (ELN) solutions for laboratories performing routine analysis in multiple industries.
price ($mm)
$11
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2011 via BusinessWire

PerkinElmer, Inc., acquired Geospiza

synopsis: PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced that it has acquired Geospiza, Inc., a leading developer of software systems for the management of genetic analysis and laboratory workflows delivered through a Web-based secure cloud computing environment.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target: Geospiza
Designed by biologists for biologists, Geospiza is the developer of GeneSifter® software, providing integrated solutions for Next Generation Sequencing analysis and LIMS. Geospiza has set the industry standard for high value, low cost, “out of the box” solutions serving the life sciences market.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/24/2011 via BusinessWire

PerkinElmer, Inc., will acquire CambridgeSoft Corporation

synopsis: PerkinElmer, Inc. has announced that it has signed a definitive agreement to acquire CambridgeSoft Corporation, a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and professional services to the pharmaceutical, biotechnology, and chemical industries.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns. "
target parent: Health Evolution Partners LLc
target: CambridgeSoft Corporation
CambridgeSoft Corporation is a leading supplier of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and professional services to the pharmaceutical, biotechnology, and chemical industries.
price ($mm)
$227
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/1/2006 via BusinessWire

PerkinElmer, Inc., acquired Spectral Genomics, Inc.

synopsis: PerkinElmer, Inc., a global technology leader in Health Sciences and Photonics, today announced the acquisition of the assets of Spectral Genomics, Inc., a leader in molecular karyotyping technology used to evaluate chromosomal abnormalities. Terms of the deal were not disclosed.
buyer: PerkinElmer, Inc. (PKI:$2,209.40)
PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. "
target: Spectral Genomics, Inc.
Spectral Genomics' array products and analysis software help pharmaceutical, biotechnology, cytogenetic and clinical researchers identify chromosomal abnormalities related to the study of cancer and pre- and post-natal genetic disorders.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Geospiza


read more

Geospiza

Applied Maths

Dotmatics

Jungla Inc.

NextBio, Inc.

Discovery Innovations, Inc.

Mavens

SnapGene

SHYFT Analytics

UNIConnect LC

CollabRX, Inc

BlueBee

HealthLytix

Cytobank

CancerGene Connect

Parabricks

read more

Geospiza

read more

Labworks LIMS

Ceiba Solutions

Labtronics Inc.

Geospiza

CambridgeSoft Corporation

Spectral Genomics, Inc.

read more
Geography
Matching Companies
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: PKI
 
 
 
 
 
 
 
 
PerkinElmer, Inc.
PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns.
year
2014
rev ($mm)
$2,209.40
EBITDA ($mm)
$414.31
EBIT ($mm)
$289.91
Net Income ($mm)
$191.79
Employees
7561
  • drill down
  • watch
Ticker: QGEN
 
 
 
 
 
 
 
 
Qiagen N.V.
Qiagen N.V.
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia.
year
2013
rev ($mm)
$1,269.61
EBITDA ($mm)
$399.44
EBIT ($mm)
$208.51
Net Income ($mm)
$35.80
Employees
4000
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: CLDA
 
 
 
 
 
 
 
 
Clinical Data, Inc.
Clinical Data, Inc.
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market.
year
2010
rev ($mm)
$13.09
EBITDA ($mm)
($78.85)
EBIT ($mm)
($81.80)
Net Income ($mm)
Employees
160
  • drill down
  • watch
Ticker: BEAT
 
 
 
 
 
 
 
 
BioTelemetry
BioTelemetry
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more.
year
2019
rev ($mm)
$386.46
EBITDA ($mm)
$110.26
EBIT ($mm)
$69.90
Net Income ($mm)
$48.52
Employees
1500
  • drill down
  • watch